Cargando…

High neutralizing antibody titer in intensive care unit patients with COVID-19

Coronavirus disease 2019 (COVID-19) has a wide spectrum of disease severity from mild upper respiratory symptoms to respiratory failure. The role of neutralizing antibody (NAb) response in disease progression remains elusive. This study determined the seroprevalence of 733 non-COVID-19 individuals f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Li, To, Kelvin Kai-Wang, Chan, Kwok-Hung, Wong, Yik-Chun, Zhou, Runhong, Kwan, Ka-Yi, Fong, Carol Ho-Yan, Chen, Lin-Lei, Choi, Charlotte Yee-Ki, Lu, Lu, Tsang, Owen Tak-Yin, Leung, Wai-Shing, To, Wing-Kin, Hung, Ivan Fan-Ngai, Yuen, Kwok-Yung, Chen, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473321/ https://www.ncbi.nlm.nih.gov/pubmed/32618497 http://dx.doi.org/10.1080/22221751.2020.1791738

Ejemplares similares

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant
por: Poon, Rosana Wing-Shan, et al.
Publicado: (2021)

Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain
por: Ip, Jonathan Daniel, et al.
Publicado: (2021)

Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
por: Zhou, Runhong, et al.
Publicado: (2020)

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples
por: Chan, Kwok-Hung, et al.
Publicado: (2021)

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Mitochondrial regulation of acute extrafollicular B‐cell responses to COVID‐19 severity
por: Cao, Tianyu, et al.
Publicado: (2022)

Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine
por: Chen, Lin-Lei, et al.
Publicado: (2022)

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant
por: Zhang, Ruiqi, et al.
Publicado: (2021)

Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong
por: Zhou, Runhong, et al.
Publicado: (2022)

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
por: Lu, Lu, et al.
Publicado: (2021)

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
por: Lu, Lu, et al.
Publicado: (2022)

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
por: Zhou, Biao, et al.
Publicado: (2022)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection
por: Yip, Cyril Chik-Yan, et al.
Publicado: (2020)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study
por: Ho-Yan Fong, Carol, et al.
Publicado: (2023)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
por: Khong, Ka-Wa, et al.
Publicado: (2022)

Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017
por: Zhu, Houshun, et al.
Publicado: (2018)

Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management
por: To, Kelvin Kai-Wang, et al.
Publicado: (2010)

Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2
por: Chen, Jonathan Hon-Kwan, et al.
Publicado: (2020)

Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection
por: Yip, Cyril Chik-Yan, et al.
Publicado: (2020)

Evolution and Control of COVID-19 Epidemic in Hong Kong
por: Wong, Shuk-Ching, et al.
Publicado: (2022)

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
por: Luo, Mengxiao, et al.
Publicado: (2023)

Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test
por: Chan, Michele Mun Hei, et al.
Publicado: (2022)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong
por: To, Kelvin Kai-Wang, et al.
Publicado: (2014)

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
por: Woo, Patrick C.Y., et al.
Publicado: (2005)

Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19)
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2020)

Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens
por: Yip, Cyril Chik-Yan, et al.
Publicado: (2020)

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults
por: Zhang, Ruiqi, et al.
Publicado: (2023)

Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
por: Chen, Lin-Lei, et al.
Publicado: (2022)

In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19
por: Lam, Athene Hoi-Ying, et al.
Publicado: (2021)

Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO "My 5 Moments for Hand Hygiene" methodology
por: Cheng, Vincent CC, et al.
Publicado: (2011)

A Novel IoT-Enabled Wireless Sensor Grid for Spatial and Temporal Evaluation of Tracer Gas Dispersion
por: Tsang, Tsz-Wun, et al.
Publicado: (2023)

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
por: Chan, Kwok-Hung, et al.
Publicado: (2013)

Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory Dysfunction
por: Chung, Tom Wai-Hin, et al.
Publicado: (2021)

Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C–C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections
por: Chiu, Kelvin Hei-Yeung, et al.
Publicado: (2023)

Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study
por: Chan, Wan-Mui, et al.
Publicado: (2021)

Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients
por: Mo, Yufei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5o686c47nm3v1e5715gri0l70e